News | Oncology Diagnostics | June 23, 2016

CT-Based Calculations Improve Accuracy of PET for Cancer Patients

Novel method of measuring lean body mass using computed tomography increases precision of molecular imaging

PET-CT, advanced cancer, lean body mass, LBM, SNMMI 2016 study

June 23, 2016 — Cancer patients often experience significant fluctuations in weight and lean body mass (LBM). Neglecting to account for these changes can prevent clinicians from obtaining precise data from molecular imaging, but a new method of measuring LBM takes changes in individual body composition into account for better staging of disease and therapy monitoring, said researchers at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 11-15 in San Diego.

Positron emission tomography (PET) has become a standard of care in cancer patient management. Fluorine-18 fluorodeoxyglucose (F-18 FDG) is a radiotracer that closely resembles the metabolic activity of glucose in cells throughout the body. F-18 FDG emits a signal that is detected by the PET scanner. Image reconstructions of these signals let clinicians know where there are areas of abnormally increased metabolic activity, quantified by standardized uptake values (SUV). Accurate tumor SUVs enable clinicians to assess disease progression, reflected by an increased SUV; stable disease, reflected by no significant changes in SUV; and successful response to therapy, reflected by a decrease in SUV.

Radiotracer tumor SUVs are quantitatively measured using patient weight. However, F-18 FDG is distributed almost exclusively in LBM, not fatty tissue. Current methods of SUV normalization tend to focus on overall weight and may significantly over- or underestimate LBM in cancer patients. For this study, researchers developed a computed tomography (CT) technique that determines patient-specific LBM. This method of SUV normalization, using patient-specific LBM, is termed SULps.

“Patients with advanced cancer tend to lose muscle and may gain fat, and these changes in body composition can significantly modify PET results, independent of the actual metabolic activity of the tumor,” said Alexander McEwan, M.D., principal author of the study from the University of Alberta Edmonton in Alberta, Canada. “Our study shows that CT-derived SULps is a more robust measurement for patients with advanced cancer undergoing PET imaging. If adopted, this simple change in imaging protocol could lead to significantly more effective care for cancer patients.”

Researchers analyzed CT scans in three-month intervals to gauge changes in body composition of patients with advanced cancer. A total of 1,080 intervals of CT were evaluated and just over 50 percent, or 546 intervals, reflected stable LBM. Of this smaller group with stable LBM, 40 percent experienced a decrease in adipose tissue, 35 percent showed no change in adipose tissue, and 25 percent showed an increase in adipose tissue. These changes affect SUV using all calculations except SULps, which accurately reflected metabolic activity via F-18 FDG PET/CT.

More precise PET measurements made with the use of CT data, could increase the accuracy of PET imaging interpretation in ground-breaking clinical trials for new cancer therapies and for more personalized medicine in the clinic.

For more information: www.snmmi.org

Related Content

An example of the MRI scans showing long-term and short-term survival indications. #MRI

An example of the MRI scans showing long-term and short-term survival indications. Image courtesy of Case Western Reserve University

News | Magnetic Resonance Imaging (MRI) | February 21, 2020
February 21, 2020 — ...
A cutting-edge magnet resonance imaging (MRI) technique to detect iron deposits in different brain regions can track declines in thinking, memory and movement in people with Parkinson's disease #Parkinsons #MRI

Summary steps of the processing pipeline for QSM reconstruction (phase pre-processing and map estimation) and whole brain/regional analysis. ANTs, advanced normalisation tools; MP-RAGE, magnetisation-prepared, 3D, rapid, gradient-echo; MSDI, multi-scale dipole inversion; QSM, quantitative susceptibility mapping; ROI, region of interest; SWI, susceptibility weighted imaging.

News | Magnetic Resonance Imaging (MRI) | February 21, 2020
February 21, 2020 — A cutting-edge...
Potassium Molybdate Mo 99 Source Vessels for RadioGenix System

Potassium Molybdate Mo 99 Source Vessels for RadioGenix System (Photo: Business Wire)

News | Radiopharmaceuticals and Tracers | February 18, 2020
February 18, 2020 — NorthStar Medical Radioisotopes, LLC, a
Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure

Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure. This picture shows a circle of hydrogel that was irradiated on the left half, which is slightly pink; whereas the right half of the gel is not irradiated and remains colorless.

News | Radiation Therapy | February 18, 2020
February 18, 2020 — More than half of all cancer patients undergo radiation therapy and the dose is critical.
SIR-Spheres Y-90 resin

SIR-Spheres Y-90 resin microspheres are released into the hepatic artery.

News | Nuclear Imaging | February 14, 2020
February 14, 2020 —  ...
Nuclear imaging equipment growth in 2020
News | Nuclear Imaging | February 14, 2020
February 14, 2020 — The nuclear imaging equipment
Accuray TomoTherapy total body irradiation
News | Radiation Therapy | February 07, 2020
February 7, 2020 — Accuray Incorporated announced that two new studies demonstrate the benefits of the ...
News | Clinical Trials | February 03, 2020
February 3, 2020 — Melding the genetic and cellular analysis of tumors with how they appear in medical images could g
Automated Triage of Thyroid Cancer

73-year-old man with papillary carcinoma of left lobe of thyroid. Screen shot shows example of thyroid nodule annotation (segmentation and TI-RADS annotation) performed on ultrasound image in longitudinal projection with electronic Physician Annotation Device software (Stanford Medicine Radiology). Radiologists performed nodule segmentation by selecting points (red) on nodule outline (green), while controlling smoothing of outline polygon by means of spline interpolation.

News | Ultrasound Imaging | January 30, 2020
January 30, 2020 — According to an ar...
A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast

A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast. (A) Unenhanced fat-saturated T1-weighted MRI shows extreme amount of FGT (ACR d). (B) Moderate BPE is seen on dynamic contrast-enhanced MRI at 90 s. (C) Mean ADC of breast parenchyma of contralateral breast on diffusion-weighted imaging with ADC mapping is 1.5 × 10?3 mm2/s. (D) On 18F-FDG PET/CT, lesion is not 18F-FDG-avid, and BPU of normal breast parenchyma is relatively high, with SUVmax of 3.2. Photo courtesy of K Pinker, et al., Medical University of Vienna, Vienna, Austria

News | PET-MRI | January 27, 2020
January 27, 2020 — Researchers have identified several potentially useful...